126 related articles for article (PubMed ID: 4962939)
21. [The neoantigens of cancer cells and their significance].
Mathé G; Amiel JL; Doré JF
Rev Fr Etud Clin Biol; 1968 Dec; 13(10):937-40. PubMed ID: 4308925
[No Abstract] [Full Text] [Related]
22. Investigation of immunizing properties as well as interferogenicity of some murine leukemia viruses.
Mazurenko NP; Revazova ES
Arch Geschwulstforsch; 1970; 35(4):308-14. PubMed ID: 4325787
[No Abstract] [Full Text] [Related]
23. Studies on the susceptibility of C57BL-6 mice to Rauscher virus. 3. Kinetics of humoral antibody response to cell-surface antigens in neonatally inoculated mice.
Ishimoto A; Ito Y
J Natl Cancer Inst; 1973 Aug; 51(2):553-64. PubMed ID: 4765372
[No Abstract] [Full Text] [Related]
24. [Antilymphocytic humoral autoimmune response of mice with developing Rauscher leukemia directed against group-specific retrovirus antigens].
Ter-Grigorov VS; Graf IA; Pivnik AV; Etkin AF; Moskovkina OIa
Eksp Onkol; 1987; 9(6):48-51. PubMed ID: 3325268
[TBL] [Abstract][Full Text] [Related]
25. Interferon and antibody production in inbred mice infected with the Rauscher virus.
Tóth FD; Váczi L; Berencsi C
Acta Microbiol Acad Sci Hung; 1971; 18(1):23-7. PubMed ID: 4335323
[No Abstract] [Full Text] [Related]
26. The development of specific cellular and humoral immunity in mice infected with Rauscher leukemia virus as neonates or adults.
McCoy JL; Fefer A; Ting RC; Glynn JP
Cancer Res; 1972 Aug; 32(8):1671-8. PubMed ID: 4339747
[No Abstract] [Full Text] [Related]
27. Antibody response of rhesus monkeys to a density gradient purified murine leukemia virus (Rauscher).
Sibal LR; Fink MA; McCune CL; Cowles CA
J Immunol; 1967 Feb; 98(2):368-73. PubMed ID: 4960063
[No Abstract] [Full Text] [Related]
28. Neutralization of sublines of a mouse leukemia virus with murine antibody, as measured by the spleen focus assay.
Sinkovics JG; Pienta RJ; Fiorentino M; Bertin BA
Cancer Res; 1967 Jan; 27(1):88-94. PubMed ID: 6020368
[No Abstract] [Full Text] [Related]
29. Antiviral antibodies inhibit the lysis of tumour cells by anti-H--2 sera.
Henning R; Schrader JW; Edelman GM
Nature; 1976 Oct; 263(5579):689-91. PubMed ID: 185524
[No Abstract] [Full Text] [Related]
30. Inheritance of susceptibility and resistance to Rauscher leukaemia virus.
Tóth FD; Váczi L; Balogh M
Acta Microbiol Acad Sci Hung; 1973; 20(3):183-9. PubMed ID: 4798829
[No Abstract] [Full Text] [Related]
31. A comparison by several techniques of the antibody prepared in various species against the Rauscher murine leukemia virus.
Fink MA; Cowles CA; Chirigos MA; Messore J
Natl Cancer Inst Monogr; 1966 Sep; 22():439-47. PubMed ID: 4958836
[No Abstract] [Full Text] [Related]
32. Effects of Rauscher leukaemia virus on the immune system in susceptible and resistant mouse strains.
Tóth FD; Karsai T; Váczi L
Acta Microbiol Acad Sci Hung; 1971; 18(4):271-8. PubMed ID: 4136204
[No Abstract] [Full Text] [Related]
33. [On the pathodynamics of proliferative processes in the spleen of NMRI-mice during the early phase of Rauscher leukemia].
Komitowski D; Goerttler K
Exp Pathol (Jena); 1974; 9(3):182-90. PubMed ID: 4435093
[No Abstract] [Full Text] [Related]
34. Contrasting immune response following Rauscher Leukemia virus infection in virus-susceptible vs. virus-resistant mice.
Meredith RF; Okunewick JP; Brozovich BJ; Weaver EV
Dev Comp Immunol; 1978 Feb; 2(1):133-46. PubMed ID: 305865
[No Abstract] [Full Text] [Related]
35. Group- and type-specific antigens in mouse leukaemia induced by Friend, Mazurenko and Rauscher viruses.
Mazurenko NP; Gurtsevich VE
Neoplasma; 1972; 19(4):277-82. PubMed ID: 4341019
[No Abstract] [Full Text] [Related]
36. The quantitation of cell surface antigens by antibody-complement mediated cytotoxicity: application to murine leukemia virus-infected mouse cells.
Moen JE; Brouwer J; Warnaar SO
J Immunol Methods; 1979; 31(3-4):251-8. PubMed ID: 93129
[TBL] [Abstract][Full Text] [Related]
37. [Comparative serologic studies on leukemia viruses. Complement fixation reaction for the determination of common antigen components occurring in leukemia viruses of various mammals].
Schäfer W; Lange J; Pister L; Seifert E; De Noronha F; Schmidt FW
Z Naturforsch B; 1970 Sep; 25(9):1029-36. PubMed ID: 4394578
[No Abstract] [Full Text] [Related]
38. Some characteristics of an isolated group antigen common to most strains of murine leukemia virus.
Fink MA; Sibal LR; Wivel NA; Cowles CA; O'Conner TE
Virology; 1969 Apr; 37(4):605-14. PubMed ID: 4305633
[No Abstract] [Full Text] [Related]
39. A salt-dependent hemagglutinating particle from measles-infected cells.
Schluederberg A; Nakamura M
Virology; 1967 Oct; 33(2):297-306. PubMed ID: 4964685
[No Abstract] [Full Text] [Related]
40. Vaccine protection by subinfectious doses of a live murine leukemia virus.
Rasmussen RA; Sharma PL; Hu Y; Ruprecht RM
Leukemia; 1999 Apr; 13 Suppl 1():S94-5. PubMed ID: 10232377
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
